Top Markets
Coin of the day
Gyre Therapeutics, Inc. Gyre Therapeutics, Inc.

Gyre Therapeutics, Inc.

GYRE
Clasificación en acciones #11143
Gyre Therapeutics, Inc. is a pharmaceutical company dedicated to discovering,... Gyre Therapeutics, Inc. is a pharmaceutical company dedicated to discovering, advancing, and bringing to market small-molecule drugs that target inflammation and fibrosis in various organs. The company's key anti-fibrotic medication, ETUARY (Pirfenidone), has received approval for treating idiopathic pulmonary fibrosis. Beyond this, ETUARY is also undergoing late-stage (Phase 3) clinical trials for several other conditions, including dermatomyositis and interstitial lung disease linked to systemic sclerosis, pneumoconiosis, and diabetic kidney disease. The company's pipeline further includes F351 (Hydronidone), a compound structurally related to ETUARY. F351 is currently in Phase 3 studies for chronic hepatitis B-induced liver fibrosis and is in Phase 1 trials for liver fibrosis associated with nonalcoholic associated steatohepatitis (NASH). Other programs in development feature F573, which is progressing through Phase 2 studies for acute and acute-on-chronic liver failure. Additionally, two early-stage candidates, F528 and F230, are in preclinical development, focusing on chronic obstructive pulmonary disease (COPD) and pulmonary arterial hypertension (PAH), respectively. Established in 2002, Gyre Therapeutics, Inc. is based in San Diego, California, and operates as a subsidiary of GNI USA, Inc.
Precio por acción
$6.61
Última sincronización: 2026-08-28
Capitalización bursátil
$736.94M
Cambio (1 día)
-1.05%
Cambio (1 año)
-14.60%
País
US
Comercio Gyre Therapeutics, Inc. (GYRE)

Categoría

Número de acciones en circulación de Gyre Therapeutics, Inc. (GYRE)
Número de acciones en circulación al August 2026: 0
Según los últimos informes financieros y el precio de las acciones de Gyre Therapeutics, Inc., el número actual de acciones en circulación es 0. Al final de August 2026, la empresa tenía 0 acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de Gyre Therapeutics, Inc. (GYRE) desde 2026 hasta 2026
Acciones en circulación al final de cada año
Año Acciones en circulación Cambiar
Not enough data for the provided dates.
Acciones en circulación de empresas similares o competidores
Empresa Acciones en circulación Diferencia País
253.90M -
US
62.19M -
NL
478.91M -
AU
396.00M -
US
- -
CH